Barclays’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
281,250
+172,688
| +159% | +$2.26M | ﹤0.01% | 1820 |
|
|
2025
Q1 | $2.39M | Sell |
108,562
-25,095
| -19% | -$552K | ﹤0.01% | 1910 |
|
|
2024
Q4 | $3.57M | Buy |
133,657
+14,307
| +12% | +$382K | ﹤0.01% | 1833 |
|
|
2024
Q3 | $3.19M | Buy |
119,350
+88,826
| +291% | +$2.37M | ﹤0.01% | 1845 |
|
|
2024
Q2 | $549K | Sell |
30,524
-56,720
| -65% | -$1.02M | ﹤0.01% | 2478 |
|
|
2024
Q1 | $1.59M | Sell |
87,244
-691,672
| -89% | -$12.6M | ﹤0.01% | 2097 |
|
|
2023
Q4 | $8.52M | Buy |
778,916
+760,637
| +4,161% | +$8.32M | ﹤0.01% | 1135 |
|
|
2023
Q3 | $105K | Buy |
18,279
+1,003
| +6% | +$5.76K | ﹤0.01% | 3315 |
|
|
2023
Q2 | $133K | Sell |
17,276
-10,740
| -38% | -$82.7K | ﹤0.01% | 3278 |
|
|
2023
Q1 | $188K | Buy |
28,016
+9,783
| +54% | +$65.6K | ﹤0.01% | 3183 |
|
|
2022
Q4 | $163K | Buy |
18,233
+8,918
| +96% | +$79.7K | ﹤0.01% | 3207 |
|
|
2022
Q3 | $91K | Sell |
9,315
-209,993
| -96% | -$2.05M | ﹤0.01% | 3447 |
|
|
2022
Q2 | $1.75M | Sell |
219,308
-652
| -0.3% | -$5.19K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $2.13M | Buy |
+219,960
| New | +$2.13M | ﹤0.01% | 1722 |
|